Clinical Trials

More research is needed to better understand DCIS.  This includes laboratory research, where scientists study patient tissue samples to learn more about the biology of DCIS, and clinical trial research.

What is a Clinical Trial?

A clinical trial is a research study involving patients that strives to answer a specific medical question.  It is the critical step when scientific inquiry and testing moves from a lab to “real world” human subjects.  Clinical trials are essential to the advancement of scientific and medical knowledge.  The data obtained from clinical trials leads to improvements in how we prevent, diagnose and treat disease.

Should I Participate in a Clinical Trial?

There are many different types of clinical trials.  Each trial has different eligibility requirements and not every patient qualifies for every trial.

There are benefits and risks to participating in any trial.  As a trial participant, you may have access to new treatments that are not available to the general public, you will be closely monitored by your medical team, and you may feel good knowing that your participation will help future patients.  There can also be downsides to participating, the main one being potential side effects from a new treatment.  Depending on the location and type of trial, you may need to travel a far distance to participate, which can cost time and money.

There are many safety protections in place for clinical trial participants. The health and well-being of participants are closely monitored and there are ongoing safety reviews by independent committees.  If at any time a trial is determined to be unsafe to participants, it is stopped.  Patients are also free to withdraw at any time.

Participating in a clinical trial is a very personal decision and one that you should make in consultation with your doctor and family. 

How Do I Find Out About Clinical Trials?

You can ask your doctor if you are eligible for any clinical trials.  Keep in mind that not every doctor knows about every clinical trial.  If you are receiving care at a research hospital, your doctor is more likely to know about clinical trials.

You can also do your own research about clinical trial options.  We recommend the following search tools:

  • BreastCancerTrials.org is a clinical trial matching service that helps people with any stage of breast cancer learn about and find clinical trials that are right for them.  It lists over 500 clinical trials that are actively recruiting patients in the United States. 
  • ClinicalTrials.gov is the U.S. government’s database of clinical trials. It includes clinical trials from around the world.

Both of these databases include tools to search by location and medical condition.  You can see trials specifically for DCIS by entering “DCIS” or “ductal carcinoma in situ” in the search box.

If you find a clinical trial on the Internet and think you might want to enroll, speak to your doctor about it.

Clinical Trials for DCIS

Clinical trials involving DCIS patients often compare a new treatment to the standard of care.  The results can inform how to refine standard of care and provide more options for future DCIS patients.

Currently, there is a very exciting clinical trial underway in the U.S. that could potentially change the standard of care for treating low risk DCIS.  Comparing an Operation to Monitoring, with or without Endocrine Therapy (COMET) trial is studying whether active monitoring (with or without hormone therapy) is a safe alternative to surgery for low-risk DCIS patients.  Similar studies are also taking place in Europe.  While COMET is no longer recruiting patients, other active monitoring trials currently recruiting patients include the RECAST trial in the United States and the LORD trial in the Netherlands.

At any given time, there are hundreds of clinical trials taking place across the U.S. and internationally involving DCIS patients.  Below is our own complication based on our own search of ClinicalTrials.gov.  To use this database, you can sort by clicking on the column headings or you can enter location or keyword terms into the search box. (If you are based in the United States, enter your state. If you are based outside the U.S., enter your country).

We try to keep this database current but due to the ever-changing nature of studies, it is neither exhaustive nor error-free. We strongly recommend confirming any information you find below with ClinicalTrials.gov and BreastCancerTrials.org for the most up-to-date information.  

Please note that we are in the process of re-designing and populating the database below and appreciate your patience while we do so.

Start YearNameStudy URLStatusLocationsKeywords
2018MRI in Ductal Carcinoma in Situ (DCIS)https://clinicaltrials.gov/study/NCT03543397UnknownStrasbourg, France
2009Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breasthttps://clinicaltrials.gov/study/NCT00857714TerminatedIndianaLapatinib
2024DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatmenthttps://clinicaltrials.gov/study/NCT06075953RecruitingBerkeley, San Francisco, California; Winston-Salem, North Carolina; Bryn Mawr, Media, Paoli, Wynnewood, Pennsylvania; Nashville, TennesseeTamoxifen; Exemestane; Letrozole; Anastrazole; Testosterone; Elacestrant; Z-endoxifen
1995Wide Excision Alone As Treatment for Ductal Carcinoma in Situ of the Breasthttps://clinicaltrials.gov/study/NCT00165256Active Not RecruitingBoston, MassachusettsObservation
2025Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)https://clinicaltrials.gov/study/NCT06868238Not Yet RecruitingMagtrace
2017Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situhttps://clinicaltrials.gov/study/NCT02908178CompletedBethesda, MarylandSentinel lymph node biopsy (SLNB)
2016Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)https://clinicaltrials.gov/study/NCT02872025Active Not RecruitingSan Francisco, CaliforniaPembrolizumab; Intralesional mRNA
2008Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)https://clinicaltrials.gov/study/NCT00669747UnknownOklahoma City, Oklahoma; Houston, TexasCarboplatin; Normal Saline
2010A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situhttps://clinicaltrials.gov/study/NCT01060345TerminatedChicago, IllinoisPolyphenon
2017Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIShttps://clinicaltrials.gov/study/NCT02926911Active Not RecruitingAnchorage, Alaska; Phoenix, Arizona; Duarte, Los Angeles, San Diego, Vallejo, California; Denver, Lafayette, Colorado; New Haven, Connecticut; Washington, District of Columbia; Hollywood, Jacksonville, Florida; Honolulu, Hawaii; Post Falls, Idaho; Chicago, Evanston, Harvey, Peoria, Rockford, Urbana, Illinois; Des Moines, Iowa City, Iowa; Kansas City, Kansas; Edgewood, Lexington, Kentucky; Baton Rouge, New Orleans, Louisiana; Brewer, Scarborough, Maine; Annapolis, Baltimore, Maryland; Boston, Massachusetts; Ann Arbor, Detroit, Grand Rapids, Royal Oak, Michigan; Minneapolis, Rochester, Saint Louis Park, Minnesota; Saint Louis, Missouri; Anaconda, Billings, Bozeman, Great Falls, Kalispell, Missoula, Montana; Omaha, Nebraska; Hooksett, New Hampshire; Englewood, Hackensack, Morristown, Neptune, Paramus, New Jersey; Albuquerque, New Mexico; Bronx, Buffalo, New York, Syracuse, New York; Chapel Hill, Charlotte, Durham, Fayetteville, Goldsboro, Greensboro, Greenville, New Bern, Raleigh, Winston-Salem, North Carolina; Belpre, Centerville, Columbus, Dayton, Delaware, Findlay, Franklin, Greenville, Kettering, Mansfield, Marietta, Marion, Newark, Westerville, Youngstown, Zanesville, Ohio; Lawton, Oklahoma; Bend, Oregon; Pittsburgh, Sayre, York, Pennsylvania; Providence, Rhode Island; Charleston, Georgetown, Greenville, South Carolina; Memphis, Tennessee; Dallas, Houston, Laredo, Texas; Salt Lake City, Utah; Burlington, Vermont; Morgantown, Norfolk, Richmond, Virginia; Bellevue, Washington; Appleton, Burlington, Fond Du Lac, Germantown, Grafton, Green Bay, Kenosha, Madison, Marinette, Milwaukee, Oshkosh, Racine, Sheboygan, Summit, Two Rivers, Wauwatosa, West Allis, WisconsinActive monitoring; Active surveillance
2021Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situhttps://clinicaltrials.gov/study/NCT05218044RecruitingGlendale, CaliforniaCryoablation; Tumor Freezing
2003MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situhttps://clinicaltrials.gov/study/NCT00586326CompletedPhoenix, Arizona; Inglewood, Los Angeles, California; Miami Beach, Florida; Baltimore, Maryland; Royal Oak, Michigan; New York, New York; Philadelphia, Pennsylvania; Providence, Rhode Island; Houston, Texas; Richmond, Virginia; Seattle, WashingtonMammoSite Radiation Therapy System
2005Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breasthttps://clinicaltrials.gov/study/NCT00496808CompletedHouston, TexasHerceptin; Trastuzumab
2016Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIShttps://clinicaltrials.gov/study/NCT02766881CompletedCanada, various location
2024Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancerhttps://clinicaltrials.gov/study/NCT06540872Not Yet RecruitingGermany, various locations[68Ga]Ga-FAPI-46
2021Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)https://clinicaltrials.gov/study/NCT03775213CompletedDurham, North CarolinaDecision Support Tool; Active Monitoring; Active Surveillance
2017Intraoperative Radiation Therapy (IORT) in DCIShttps://clinicaltrials.gov/study/NCT03216421Active Not RecruitingNew York, New YorkQuality of Life Questionnaires
2018Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgeryhttps://clinicaltrials.gov/study/NCT03535506TerminatedWashington, District of ColumbiaPalbociclib
2019A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situhttps://clinicaltrials.gov/study/NCT04144023RecruitingJacksonville, Florida; Rochester, MinnesotaGranulocyte-Macrophage Colony-Stimulating Factor; Multi-epitope HER2 Peptide Vaccine H2NVAC; Echocardiography; Biospecimen Collection; Biopsy
2015MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situhttps://clinicaltrials.gov/study/NCT02352883Active Not RecruitingSan Diego, San Marcos, California; Greenwich, Hartford, Meriden, New Britain, Connecticut; Newark, Delaware; Atlantis, Florida; Chicago, Harvey, Naperville, Plainfield, Springfield, Illinois; Avon, Indianapolis, Mishawaka, South Bend, Indiana; Dodge City, El Dorado, Lawrence, Salina, Wellington, Wichita, Winfield, Kansas; Owensboro, Kentucky; Baton Rouge, New Orleans, Louisiana; Salisbury, Maryland; Minneapolis, Minnesota; Saint Louis, Springfield, Missouri; Flemington, Mount Holly, Somerville, Voorhees, New Jersey; Bronx, New York; Asheville, Winston-Salem, North Carolina; Canton, Cincinnati, Ohio; Bryn Mawr, Easton, Gettysburg, Hershey, Media, Paoli, Philadelphia, Phoenixville, Pottstown, Wynnewood, York, Pennsylvania; Providence, Rhode Island; Spartanburg, South Carolina; Dallas, Texas; Salt Lake City, Utah; Seattle, Washington; Oconomowoc, Waukesha, Wausau, WisconsinMRI; Radiation; Endocrine Therapy; Quality-of-Life Assessment; Biomarker; Cytology
2009Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)https://clinicaltrials.gov/study/NCT01023477CompletedFairfax, Falls Church, VirginiaChloroquine; Biopsy
2022Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)https://clinicaltrials.gov/study/NCT04797299RecruitingCanada, various locations
2008Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breasthttps://clinicaltrials.gov/study/NCT01841749CompletedBordeaux, Aquitaine, FranceSentinel node biopsy; Mastectomy
2007Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breasthttps://clinicaltrials.gov/study/NCT00470236UnknownVarious location in Australia (including locations in New South Wales, Queensland, South Australia and Tasmania; Belgium; Canada; France; Ireland; Italy; Netherlands; New Zealand; Singapore; Switzerland; United KingdomRadiation; Fractionation
2004Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Womenhttps://clinicaltrials.gov/study/NCT00256217CompletedOrange, CaliforniaAnastrozole
2016Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancerhttps://clinicaltrials.gov/study/NCT02636582CompletedBoston, Massachusetts; New York, New York; Philadelphia, Pennsylvania; Houston, TexasBiomarker; Nelipepimut-S Plus GM-CSF Vaccine; Sargramostim
2025The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIShttps://clinicaltrials.gov/study/NCT06217458Not Yet RecruitingCroatiaContrast Enhanced Mammography
2006Breast MRI as a Preoperative Tool for DCIShttps://clinicaltrials.gov/study/NCT00605982Active Not Recruiting Basking Ridge, New Jersey; Commack, New York, New YorkMRI
2015Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancerhttps://clinicaltrials.gov/study/NCT02127073Terminated New York, New YorkIntranasal Oxytocin
2019Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breasthttps://clinicaltrials.gov/study/NCT03878342Active Not RecruitingFrance, various locationsRadiation; Radiotherapy
2023Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIShttps://clinicaltrials.gov/study/NCT05912569RecruitingSeoul, KoreaDelay sentinel node biopsy
2009DC Vaccine for Patients With Ductal Carcinoma In Situhttps://clinicaltrials.gov/study/NCT02061332CompletedPhiladelphia, PennsylvaniaHER-2 Pulsed Dendritic cell Vaccine
2017Management of Low-risk (Grade I and II) DCIShttps://clinicaltrials.gov/study/NCT02492607RecruitingNetherlands, various locationsDigital Mammography; Radiation; Radiotherapy
2016Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)https://clinicaltrials.gov/study/NCT03148015CompletedNewport News, VirginiaBiomarkers
2017The PROMISE Study: Duavee in Women With DCIShttps://clinicaltrials.gov/study/NCT02694809CompletedAurora, Colorado; Chicago, Geneva, Lake Forest, Illinois; Baltimore, Maryland; Boston, Massachusetts; Saint Louis, Missouri; Philadelphia, Pittsburgh, Pennsylvania; Salt Lake City, UtahConjugated Estrogens/Bazedoxifene; Biomarker; Placebo; Quality-of-Life Assessment; Questionnaire Administration
2017Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breasthttps://clinicaltrials.gov/study/NCT02993159CompletedChicago, Illinois; Edgewood, Kentucky; Rochester, Minnesota; New York, New York; Durham, North Carolina; Cleveland, OhioAfimoxifene; Biomarker; Placebo; Tamoxifen Citrate
2024Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situhttps://clinicaltrials.gov/study/NCT06218303RecruitingPittsburgh, PennsylvaniaMUC1 Peptide Vaccine; Hiltonol®; Aromatase Inhibitor
2010Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible Candidateshttps://clinicaltrials.gov/study/NCT05961280CompletedMastectomy; Sentinel lymph node biopsy
2020Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situhttps://clinicaltrials.gov/study/NCT04722692RecruitingHouston, Texas; Hong Kong; Sweden, various locations
2012A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situhttps://clinicaltrials.gov/study/NCT01628536CompletedNew Haven, ConnecticutBlack cohosh
2013Impact of Radiation Therapy on Breast Conservation in DCIShttps://clinicaltrials.gov/study/NCT02248662CompletedBoston, Massachusetts; Hanover, New Hampshire; Madison, Wisconsin
2006A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)https://clinicaltrials.gov/study/NCT00183963TerminatedLos Angeles, CaliforniaTamoxifen; Fulvestrant
2008Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)https://clinicaltrials.gov/study/NCT00804128CompletedSan Francisco, CaliforniaMagnetic Resonance Imaging; MRI; Gadavist
2019Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situhttps://clinicaltrials.gov/study/NCT04046159RecruitingTaipei, TaiwanLow-dose Tamoxifen; Radiation; Radiotherapy
2020Subzero and Scorpion Trialhttps://clinicaltrials.gov/study/NCT05032079WithdrawnMiami, FloridaCryoablation
2019Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumorshttps://clinicaltrials.gov/study/NCT02856503WithdrawnVitamin D3
2008Intraoperative Gamma Camera for Breast Cancer Surgeryhttps://clinicaltrials.gov/study/NCT00757302CompletedStrasbourg, FranceSLN procedure (CarolIReS camera)
2019Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIShttps://clinicaltrials.gov/study/NCT03703492CompletedMadison, Wisconsin(18F)FES|DRGadobenate dimeglumine
2009Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situhttps://clinicaltrials.gov/study/NCT00555152CompletedBirmingham, Alabama; Houston, TexasBiomarker; Lapatinib Ditosylate; Placebo
2011Diagnostic Study of Early Breast Cancer Using Ultrasoundhttps://clinicaltrials.gov/study/NCT01391039TerminatedToronto, Ontario, CanadaPerflutren lipid microsphere
2013The Prone Breast Radiation Therapy Trialhttps://clinicaltrials.gov/study/NCT01815476CompletedCanada, various locationsRadiation Therapy Positioning Intervention
2007Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breasthttps://clinicaltrials.gov/study/NCT00556907TerminatedLos Angeles, CaliforniaRadiation; Intraoperative radiotherapy
2008Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomyhttps://clinicaltrials.gov/study/NCT00769379Active Not RecruitingAlabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; District of Columbia; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington; West Virginia; Wisconsin; Wyoming; various locations; Canada, various location; Seoul, Korea; San Juan, Puerto RicoBiomarker; Trastuzumab; Radiation; Whole Breast Irradiation
2011Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitorhttps://clinicaltrials.gov/study/NCT01372618TerminatedNew York, New YorkSOM 230 / Pasireotide
2023LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancerhttps://clinicaltrials.gov/study/NCT05900986RecruitingScottsdale, Arizona; Washington, District of Columbia; Weston, Florida; Bronx, New York, Winston-Salem, North Carolina; Cleveland, Ohio; Philadelphia, Pennsylvania; Dallas, Houston, TexasLS301-IT
2019Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinomahttps://clinicaltrials.gov/study/NCT03909282RecruitingStanford, CaliforniaLumpectomy; Radiation; Partial breast irradiation
2016A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestranthttps://clinicaltrials.gov/study/NCT02540330TerminatedBaltimore, Maryland; Bronx, New York, New YorkFulvestrant
2018MRI Characterization of Mammographically Detected DCIShttps://clinicaltrials.gov/study/NCT03495011Active Not RecruitingSeattle, WashingtonMRI; Biomarker
2009Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)https://clinicaltrials.gov/study/NCT00890994CompletedRochester, Minnesota
2015CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)https://clinicaltrials.gov/study/NCT02365714TerminatedWashington, District of ColumbiaRadiation; CK Stereotactic Accelerated Partial Breast Irradiation
2008Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgeryhttps://clinicaltrials.gov/study/NCT00671476UnknownEureka, Santa Monica, Californiapegylated liposomal doxorubicin hydrochloride; DNA methylation; TdT-mediated dUTP nick end labeling assay; fluorescence in situ hybridization; loss of heterozygosity; polymerase chain reaction; immunoenzyme; immunohistochemistry staining; biomarker; breast duct lavage
2010Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancerhttps://clinicaltrials.gov/study/NCT01112254CompletedVillejuif, FranceMagnetic Resonance Imaging; MRI, biopsy
2009Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breasthttps://clinicaltrials.gov/study/NCT00788112CompletedSan Francisco, Californiavorinostat; protein expression; immunohistochemistry staining; biomarker
2024Role of MRI Breast in Detection of Ductal Carcinoma in Situhttps://clinicaltrials.gov/study/NCT06744140Active Not RecruitingLahore, Punjab, PakistanMagnetic Resonance Imaging; MRI
2018Ruxolitinib for Premalignant Breast Diseasehttps://clinicaltrials.gov/study/NCT02928978Active Not RecruitingBirmingham, Alabama; Indianapolis, Indiana; Bronx, New York, Chapel Hill, North Carolina; Nashville, Tennessee; Houston, TexasRuxolitinib; Placebo
2012Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situhttps://clinicaltrials.gov/study/NCT01439711CompletedVarious locations in California, Colorado, Delaware, Iowa, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Missouri, North Carolina, Ohio, Oklahoma, South Carolina, Texas, Virginialetrozole; MRI
2023Reoperation Rate in Breast-Conserving Surgery Using Confocal Histolog® Scanner for Intraoperative Margin Assessmenthttps://clinicaltrials.gov/study/NCT05946759CompletedPaderborn, GermanyHistolog Scanner
2023Excisional Vacuum-Assisted Breast Biopsyhttps://clinicaltrials.gov/study/NCT05932758Recruiting Milan, ItalyExcisional biopsy
2022An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"https://clinicaltrials.gov/study/NCT04349111WithdrawnIntra-operative Radiation Therapy - IORT
2005Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breasthttps://clinicaltrials.gov/study/NCT00107211CompletedPhiladelphia, Pennsylvaniatherapeutic autologous dendritic cells
2024A Patient Navigation Program for Addressing Disparities in Breast Cancer Carehttps://clinicaltrials.gov/study/NCT06350500RecruitingBuffalo, New YorkPatient Navigation; Questionnaire
2014Effects of Diet and Exercise on Ductal Carcinoma in Situhttps://clinicaltrials.gov/study/NCT02224807CompletedBirmingham, AlabamaProgressive Resistance Training (PRT); healthy diet; weight loss
2003Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situhttps://clinicaltrials.gov/study/NCT00072462CompletedVarious locations in Australia, Austria, Belgium, Chile, France, Germany, Hungary, Ireland, Italy, Malta, Sweden, Switzerland, Turkey, United KingdomTamoxifen citrate; Anastrozole
2021Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situhttps://clinicaltrials.gov/study/NCT04666961RecruitingFrance, various locationsTamoxifen; Anastrozole
2012Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®https://clinicaltrials.gov/study/NCT01644669Active Not RecruitingVarious locations in Arizona, California, Colorado, Florida, Illinois, Indiana, Maryland, New Hampshire, New York, Oklahoma, Tennessee, Virginia; Australia; PortugalIntra-operative Radiation Therapy - IORT
2009Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsyhttps://clinicaltrials.gov/study/NCT00843167CompletedKnight Cancer Institute at Oregon Health and Science University, Portland, Oregon, 97239-3098, United StatesDiet; Broccoli sprout extract; Placebo
2020Molecular Analysis of the Sloane Projecthttps://clinicaltrials.gov/study/NCT05868252Enrolling By InvitationLondon, United Kingdom
2004Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancerhttps://clinicaltrials.gov/study/NCT00896857CompletedRNA; polymerase chain reaction; protein expression; reverse transcriptase-polymerase chain reaction; western blotting; immunoenzyme; immunohistochemistry staining; biomarker; breast duct lavage
2003Educational Interventions for Patients With DCIShttps://clinicaltrials.gov/study/NCT00148655CompletedBoston, MassachusettsDecision Board
2007Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasiahttps://clinicaltrials.gov/study/NCT00627276CompletedPortland, OregonDiet; omega-3 fatty acid; placebo
2018Abbreviated Breast MRI After Cancer Treatmenthttps://clinicaltrials.gov/study/NCT03664778Active Not RecruitingPhiladelphia, Pennsylvania